Skip to main content
SpringerLink
Log in

Isn’t the efficacy of antidepressants clinically relevant? A critical comment on the results of the metaanalysis by Kirsch et al. 2008

  • REVIEW
  • Published:
European Archives of Psychiatry and Clinical Neuroscience Aims and scope Submit manuscript

Abstract

The metaanalysis of Kirsch (PLoS Med 5:e45, 2008) has (unfortunately!) attracted too much attention in the specialized press and especially in the lay press. Therefore, intensive critical commenting is necessary to not further alarm experts and health authorities as well as patients and family members. The specified commenting on these metaanalyses shall be prefaced with a short and critical commentary regarding the general significance of metaanalyses. The results of metaanalyses should not too naively be interpreted as the ‘truth’ as regards to the evidence based psychopharmacotherapy, but should be qualified in their significance due to principal methodological reasons Maier (Nervenarzt 78:1028–1036, 2007; Möller (Nervenarzt 78:1014–1027, 2007). Especially from these derived effect sizes should be interpreted carefully.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Anderson IM (2000) Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. J Affect Disord 58:19–36

    Article  PubMed  CAS  Google Scholar 

  2. Baghai TC, Volz HP, Moller HJ (2006) Drug treatment of depression in the 2000s: an overview of achievements in the last 10 years and future possibilities. World J Biol Psychiatry 7:198–222

    Article  PubMed  Google Scholar 

  3. Baldwin D, Broich K, Fritze J, Kasper S, Westenberg H, Möller HJ (2003) Placebo-controlled studies in depression: necessary, ethical and feasible. Eur Arch Psychiatry Clin Neurosci 253: 22–28

    Article  PubMed  Google Scholar 

  4. Bauer M, Bschor T, Pfennig A, Whybrow PC, Angst J, Versiani M, Moller HJ (2007) World federation of societies of biological psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders in primary care. World J Biol Psychiatry 8:67–104

    Article  PubMed  Google Scholar 

  5. Fritze J, Aldenhoff J, Bergmann F, Maier W, Möller HJ (2005) Antidepressiva: Lebensgefährliche Placebos? Arznei-Telegramm: fahrlässiges journal? Psychoneuro 31:480–484

    Article  Google Scholar 

  6. Fritze J, Möller HJ (2001) Design of clinical trials of antidepressants. Should a placebo control arm be included? CNS Drugs 15(10):755–764

    Article  PubMed  CAS  Google Scholar 

  7. Geddes JR, Carney SM, Davies C, Furukawa TA, Kupfer DJ, Frank E, Goodwin GM (2003) Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet 361:653–661

    Article  PubMed  CAS  Google Scholar 

  8. Kirsch I, Moore TJ, Scoboria A, Nicholls S (2002) The emperor's new drugs: an analyses of antidepressant medication data submitted to the U.S. Food and Drug Administration. Prevention & Treatment 5 (Artikle 23)

  9. Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT (2008) Initial severity and antidepressant benefits: a meta-analysis of data submitted to the food and drug administration. PLoS Med 5:260–268

    Article  Google Scholar 

  10. Maier W, Möller HJ (2007) Metaanalysen. Methoden zur Evidenzmaximierung von Therapiestudien. Nervenarzt 78: 1028–1036

    Article  PubMed  CAS  Google Scholar 

  11. Möller HJ (2008a) Is there a need for a new psychiatric classification at the current state of knowledge? World J Biol Psychiatry 9:82–85

    Article  PubMed  Google Scholar 

  12. Möller HJ (2008b) Methodik empirischer Forschung. In: Möller HJ, Laux G, Kapfhammer H-P (eds) Psychiatrie und psychotherapie. Springer, Heidelberg, pp 346–367

    Google Scholar 

  13. Möller HJ, Maier W (2007) Probleme der “evidence-based medicine” in der Psychopharmakotherapie. Problematik der Evidenzgraduierung und der Evidenzbasierung komplexer klinischer Entscheidungsprozesse. Nervenarzt 78:1014–1027

    Article  PubMed  Google Scholar 

  14. Montgomery SA, Kasper S (2007) Severe depression and antidepressants: focus on a pooled analysis of placebo-controlled studies on agomelatine. Int Clin Psychopharmacol 22:283–291

    Article  PubMed  Google Scholar 

  15. Montgomery SA, Möller HJ (2008) The clinical relevance of the significant advantage of escitaloprom compared to other antidepressants. (in preperation)

  16. National Institute for Clinical Excellence (2004) Depression: management of depression in primary and secondary care. Clinical practice guideline no 23. National Institute for Clinical Excellence, London

    Google Scholar 

  17. Nutt DJ, Sharpe M (2008) Uncritical positive regard? Issues in the efficacy and safety of psychotherapy. J Psychopharmacol 22:3–6

    Article  PubMed  Google Scholar 

  18. Russh AJ (2007) STAR*D: what have we learned? Am J Psychiatry 164:201–204

    Article  Google Scholar 

  19. Storosum JG, Elferink AJ, van Zwieten BJ, van den BW, Gersons BP, van Strik R, Broekmans AW (2001) Short-term efficacy of tricyclic antidepressants revisited: a meta-analytic study. Eur Neuropsychopharmacol 11:173–180

  20. Turner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R (2008) Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med 358:252–260

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Chairman of the Department of Psychiatry, Ludwig-Maximilians-University Munich, Nussbaumstraße 7, 80336, Munich, Germany

    Hans Jürgen Möller

Authors
  1. Hans Jürgen Möller
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hans Jürgen Möller.

Additional information

The metaanalysis of Kirsch has (unfortunately!) attracted too much attention in the specialized press and especially in the lay press. Therefore, intensive critical commenting is necessary to not further alarm experts and health authorities as well as patients and family members.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Möller, H.J. Isn’t the efficacy of antidepressants clinically relevant? A critical comment on the results of the metaanalysis by Kirsch et al. 2008. Eur Arch Psychiatry Clin Neurosc 258, 451–455 (2008). https://doi.org/10.1007/s00406-008-0836-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00406-008-0836-5

Keywords

Search

Navigation